The Chairman of the Pharmaceutical Authority discusses with the Philippine Authority investment opportunities and enhancing the export of pharmaceutical exports
Dr. Ali Al-Ghamrawi, Chairman of the Egyptian Medicines Authority, held a bilateral meeting with the delegation of the Philippine Food and Drug Authority (FDA Philippines), headed by Dr. Jesusa Joyce Seronay, Director of the International Regulatory Operations Policy Committee (IROPC), at the headquarters of the European Medicines Agency (EMA) in Amsterdam, the Netherlands, during his participation in the International Alliance of Regulatory Authorities Summit. ICMRA for the year 2025.
The two sides discussed opportunities to establish a regulatory and economic partnership aimed at promoting fair and sustainable access to high-quality medicines at reasonable prices, in addition to developing bilateral trade exchange between Egypt and the Philippines in the pharmaceutical sector.
The meeting also discussed ways to enhance regulatory convergence and accreditation based on the results of the World Health Organization (WHO) evaluation. Benchmarking), in light of the Egyptian Medicines Authority obtaining the third maturity level (ML3) from the organization, which qualifies it to provide technical support and transfer regulatory expertise to partner countries.
The meeting included discussing the implementation of capacity-building programs through training visits and joint technical programs, in a way that enhances the efficiency of regulatory cadres in the two countries.
Dr. Ali Al-Ghamrawi confirmed, during the meeting, that the Authority is proceeding With steady steps towards strengthening its international presence and expanding areas of cooperation with global regulatory bodies, in line with the vision of the Egyptian state in supporting regional integration and building effective strategic partnerships in the field of medicine.
Al-Ghamrawi pointed out that the Egyptian Drug Authority possesses advanced regulatory and technical capabilities that qualify it to be a reliable partner in supporting pharmaceutical systems in friendly countries, stressing the authority’s keenness to transfer its expertise. Regulatory and technical support will contribute to raising the efficiency of the pharmaceutical sector globally and achieving sustainable drug security that serves the people.
For her part, Dr. Jesusa Joyce Sironay, Director of the International Regulatory Operations Policy Committee at the Philippine Food and Drug Authority, expressed – She expressed her appreciation for the pioneering role played by the Egyptian Medicines Authority at the regional and international levels, stressing that the Authority represents a distinguished model in developing the regulatory system in line with international standards.
She praised the remarkable development in the performance of the Egyptian Medicines Authority after it obtained the third maturity level (ML3) from the World Health Organization, noting the aspiration of the Philippine side to strengthen joint cooperation frameworks and benefit from its advanced expertise. In the areas of pharmaceutical evaluation, quality assurance, and supporting regulatory capabilities.
The attendees agreed on the importance of the strategic partnership in enhancing the access of Egyptian medicine to Asian markets, in support of the state’s efforts to increase pharmaceutical exports and open new markets for national products. Opportunities for exporting Egyptian medicine to the Philippines were also discussed to achieve integration in meeting the pharmaceutical needs between the two countries.
The meeting was attended by On the side of the Egyptian Medicines Authority, Dr. Osama Hatem, Assistant to the Chairman of the Authority for Policy Affairs and International Cooperation and Supervisor of the Central Administration for Pharmaceutical Policies and Market Support, Dr. Sondos Mohamed, Supervisor at the General Administration of Public Relations and International Cooperation.
And on the Philippine side, Vanessa Olivar Malilang, Planning Officer at the Philippine Food and Drug Authority.
At the conclusion of the meeting, the two sides expressed their appreciation. Due to the depth of bilateral relations between Egypt and the Philippines, stressing their keenness to continue coordination and expand the horizons of regulatory and economic cooperation, which contributes to supporting the pharmaceutical system regionally and internationally.
These efforts come within the framework of the Egyptian Medicines Authority’s endeavor to strengthen its regional and international presence as a leading body in the fields of pharmaceutical cooperation and regulation, and to consolidate Egypt’s position as an effective diplomatic force in the health sector. And pharmaceutical, and contribute to supporting pharmaceutical regulatory systems in friendly countries in accordance with international best practices.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related
